SHINE Technologies’ production process results in molybdenum-99 that is of high quality and high purity, resulting in Mo-99 that has high specific activity and is ready for delivery to our medical customers. We believe our production of Mo-99 in the United States will contribute to the reliability of SHINE’s supply in a time of chronic shortages of medical isotopes.

Mo99 is the parent isotope of technetium99m, a light-emitting element that is administered to tens of thousands of Americans every day for the purpose of diagnosing and staging a multitude of diseases, including cancer and heart disease.

SHINE will produce Mo99, which is then loaded into Tc99m generators. As Mo99 turns into Tc99m within the generator, the Tc99m can be extracted by radiopharmacy staff for use in imaging procedures.

Download our brochure to learn more about Mo-99